Clinical Trials - Phase I

Found 19,649 articles

• Evotec OAI (United Kingdom) Successfully Completes Single Ascending Dose Component Of Phase I Trial With EVT 101 For Alzheimer's Disease

  2/3/2006

• Ecopia BioSciences Inc. Receives No Objection Letter From Health Canada For Cancer Phase I Clinical Trial

  2/3/2006

• Regeneration Technologies Inc.'s VEGF Trap Demonstrates Positive Preliminary Results In Patients With Age-Related Macular Degeneration

  2/3/2006

• ArQule, Inc. Announces Initiation Of Phase 1 Trial With c-Met Inhibitor

  2/2/2006

• Halozyme Therapeutics, Inc. Initiates Clinical Trial Of Subcutaneous Morphine With Hylenex

  2/2/2006

• Biocryst Pharmaceuticals And Mundipharma International Limited Collaborate On Development Of Fodosine(TM)

  2/2/2006

• Abeille Pharmaceuticals, Inc. Initiates Phase I Clinical Trial Of AB-1001 For Prevention Of Emesis Associated With Chemo- And Radiation Therapy

  2/1/2006

• Eli Lilly and Company Initiates Clinical Trials On Second Cancer Drug Discovered In Isis Pharmaceuticals, Inc. Collaboration

  2/1/2006

• PharmaMar S.A. Release: FDA Grants IND For FDA's ZALYPSISÒ To Enter Phase I Clinical Trials In US

  1/31/2006

• Sunesis Pharmaceuticals, Inc. Commences Phase I Clinical Trial Of SNS-032 For Cancer

  1/31/2006

• ZIOPHARM, Inc. Initiates ZIO-101 Phase I/II Myeloma Study; Company Meets Milestone For Treatment Of First Patient

  1/31/2006

• DOR BioPharma, Inc. Announces Positive Phase I Results Of RiVax(TM), Its Vaccine Against Ricin Toxin

  1/31/2006

• LifeCycle Pharma Heads Into Pivotal Trials With Its Immunosuppression Product

  1/31/2006

• IDM Pharma, Inc. Presents Results Of Its Phase I Trial Of Its Collidem(R) Dendritic Cell Vaccine In Patients With Advanced Colorectal Cancer At GI-ASCO Meeting In San Francisco

  1/30/2006

• Pharmos Corporation Completes Phase I Cannabinor Study

  1/27/2006

• GPC Biotech, Inc. Release: Orphan Drug Designation Granted By European Commission For Anticancer Monoclonal Antibody 1D09C3 For Chronic Lymphocytic Leukemia

  1/27/2006

• Sirna Therapeutics, Inc. Announces Presentation Of Multiple Published Abstracts At The Keystone Symposium On RNAi And Related Pathways

  1/26/2006

• Targeted Genetics Corporation Cuts Jobs By About 27% In Restructuring Plan

  1/25/2006

• Curis, Inc. Shares Plunge On Basal Cell Carcinoma Phase I Clinical Trial Results

  1/25/2006

• Roche Plans Clinical Trial With MorphoSys-Generated Alzheimer Antibody

  1/25/2006